Amber DoironResearch Interests: Nanotechnology, biomaterials, drug delivery, molecular imaging, atherosclerosis.
Phone: 607-777-5477
Office: Room 2625
Our lab is interested in creating nanoparticles for drug delivery and molecular imaging with a focus on detection and treatment of atherosclerosis (heart disease). The design of nanoparticles at a molecular level can have a large influence on particle function, targetability, and toxicity. By understanding the impact of the chemical building blocks, we aim to create nanoparticles that better detect or treat disease with fewer side effects than conventional agents. Along with this, we aim to develop nanoscale polymeric biomaterials that are temperature sensitive, adding a new level of specificity to mediate the interactions of nanoparticles with their environment. The overall motivation of our lab is to better human health through earlier disease detection, more specific detection of disease severity, and improved understanding of the impact of nanoparticles on living systems.
Postdoctoral Fellow-Chemical Engineering and Radiology, University of Calgary, Alberta, Canada 2009-2012
Ph.D.-Biomedical Engineering, University of Texas at Austin, 2008
M.S.-Biomedical Engineering, University of Texas at Austin, 2007
B.S.-Chemistry, Colorado State University, Fort Collins, CO, 2003
Assistant Professor - Bioengineering, Binghamton University, Binghamton, NY, 2012-present
T. Chen Fong Postdoctoral Fellowship in Medical Imaging, University of Calgary, 2010-2011.
Materials science/nano, micro, bio & MEMS Engineering Poster Award, 2007 Graduate and Industry Networking (GAIN) Conference, UT-Austin
Overall Outstanding Poster Award, 2007 GAIN Conference, UT-Austin
National Science Foundation IGERT Graduate Research Fellowship, University of Texas at Austin, 2004 – 2006
Thrust 2000 Fellowship, University of Texas at Austin, 2004 – 2008
Women in Engineering Program Participant Scholarship, 2006, 2007, 2008
Conference Chairman’s Student Poster Award, 2004 Rocky Mountain Bioengineering Symposium
Lucent Technologies National Academic Award, 1999 - 2002
Colorado Distinguished Scholars Award, Colorado State University, 1999 – 2003
Colorado State University President’s Scholarship, 2000 – 2001
Robert C. Byrd Honors Scholarship, State of Colorado, 1999 – 2003
Ival Goslin Engineering Honors Scholarship, 1999 – 2000
Doiron A.L., Steele R., Jiang S.X.Y., Shepherd R., Childs S., Rinker K.D. Nanoparticle localization in blood vessels to regions of disturbed flow. Nanomedicine: Nanotechnology, Biology, Medicine, Submitted 2012.
Yaehne K., Clancy A., Gregoriou Y., Walker J. Tekrony A., Nguyen T., Doiron A., Rinker K., Jiang S., Childs S., Cramb D. Nanoparticle accumulation in angiogenic tissues: The good, the bad and the predictable. ACS Nano, Submitted 2012.
Doiron A.L., Clark B., Rinker K.D. (2011). Endothelial nanoparticle binding kinetics are matrix and size dependent. Biotechnology and Bioengineering 108(12) 2988–2998.
Aulanier A-L., Doiron A. L., Shepherd R. D., Rinker K. D., Frayne R., & Andersen L. B. (2010). A human cell model for dynamic testing of MR contrast agents. Biotechniques Journal 50(2) 120-123.
Doiron A. L., Homan K. A., Emelianov S., & Brannon-Peppas L. (2009). Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharmaceutical Research 26(3) 674-682.
Doiron A. L., Chu K., Ali A., & Brannon-Peppas L. (2008). Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proceedings of the National Academy of Sciences 105(45) 17232-17237.
Doiron A., Betancourt T., Homan K., & Brannon-Peppas L. (2008). Controlled release and nanotechnology. In M. M. de Villiers, P. Aramwit, & G. S. Kwon (Eds.), Nanotechnology in Drug Delivery.
Doiron A. L., Chu K. S., & Brannon-Peppas L. (2007). PLGA microparticles
containing Gd-DTPA for imaging. Transactions of the 34th Annual Meeting & Exposition of the Controlled Release Society, No. 518.
Betancourt T., Doiron A., & Brannon-Peppas L. (2006). Polymeric nanoparticles for tumor-targeted drug delivery. In M. M. Amiji (Ed.), Nanotechnology in cancer therapeutics. Boca Raton, FL: CRC Press.
Doiron A., & Brannon-Peppas L. (2006). Nanoparticles for the delivery of imaging agents to atherosclerotic plaque, Transactions of the 33rd Annual Meeting & Exposition of the Controlled Release Society, No. 780.
Doiron A. L., Kirkpartrick A. P., & Rinker K. D. (2004). TGF-β and TNF-α affect cell surface proteoglycan and sialic acid expression on vascular endothelial cells, Biomedical Sciences Instrumentation, 40, 331-336.
Assistant Professor- Bioengineering, Binghamton University, Binghamton, NY, 2012-present
